Table 1 Clinicopathological characteristics of patients with mSBA and comparison of the characteristics between the primary tumour location in the duodenum/ jejunum and ileum
Primary tumour location | Total | Duodenum/ Jejunum | Ileum | P value |
|---|---|---|---|---|
All, n | 74 | 65 (38/ 27) | 9 | Â |
Sex (male), n (%) | 49 (66.2) | 44 (67.7) | 5 (55.6) | 0.475 |
Age > 65 years, n (%) | 45 (60.8) | 42 (64.6) | 3 (33.3) | 0.141 |
PS 0 or 1, n (%) | 67 (90.5) | 58 (89.2) | 9 (100.0) | 0.586 |
Complication of cancer in another organ, n (%) | 21 (28.8) | 19 (29.2) | 2 (25.0) | 1.000 |
Histological type (differentiated), n (%) | 57 (77.0) | 50 (76.9) | 7 (77.8) | 1.000 |
Number of metastatic organs > 2, n (%) | 18 (24.3) | 15 (23.1) | 3 (33.3) | 0.679 |
Metastasis site | ||||
 Liver, n (%) | 26 (35.1) | 23 (35.4) | 3 (33.3) | 1.000 |
 Lung, n (%) | 5 (6.8) | 4 (6.2) | 1 (11.1) | 0.487 |
 Lymph node, n (%) | 21 (28.4) | 18 (27.7) | 3 (33.3) | 0.707 |
Peritoneal dissemination, n (%) | 25 (33.8) | 21 (32.3) | 4 (44.4) | 0.475 |
Resection of primary tumour, n (%) | 41 (55.4) | 33 (50.8) | 8 (88.9) | 0.037 |
Post-operative recurrence, n (%) a | 9 (12.2) | 7 (10.8) | 2 (22.2) | 0.299 |
CEA > 5 ng/ml, n (%) (n = 73) | 35 (48.0) | 29 (45.3) | 6 (66.7) | 0.296 |
CA19–9 > 37 U/ml, n (%) (n = 73) | 34 (46.6) | 31 (48.4) | 3 (33.3) | 0.489 |